Results 271 to 280 of about 807,862 (404)

Hematopoietic stem cell heterogeneity and age-related platelet bias: implications for bone marrow transplantation and blood disorders. [PDF]

Stem Cell Res Ther
Chen Y, Shentu J, Lou H, Xia Y, Jiang Y, Duan S.   +5 more
europepmc   +1 more source

SYSTEMIC EVALUATION OF SJÖGREN-LIKE SYNDROME AFTER BONE MARROW TRANSPLANTATION IN MAN

, 1987
A Janin-Mercier, A. DEVERGIE, J. P. Arrago, C Brochériou, F Lemarchand-Vénencie, J D Rain, Éliane Gluckman   +6 more
openalex   +1 more source

Bone marrow transplantation. [PDF]

Archives of Disease in Childhood, 1981
openaire   +2 more sources

Prediction of neutrophil nadir and recovery following paediatric haematopoietic cell transplantation with busulfan conditioning

British Journal of Clinical Pharmacology, EarlyView.
Aims In haematopoietic cell transplantation (HCT), neutropenia resulting from myelosuppression is an expected endpoint following busulfan‐based conditioning. However, if prolonged, neutropenia can lead to complications like serious infection and death.
Beth Apsel Winger, Joseph W. Polli, Janel Long‐Boyle, Andrew Weber, Jordan Brooks, Jaimit Parikh, Valeriu Damian   +6 more
wiley   +1 more source

HLA-matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AML. [PDF]

EJHaem
Mitsuyoshi T, Arai Y, Kondo T, Kawata T, Hirabayashi S, Tanaka M, Mori Y, Doki N, Nishida T, Kotani T, Ogata M, Tabayashi T, Eto T, Sawa M, Imada K, Kanda J, Ichinohe T, Atsuta Y, Yanada M.   +18 more
europepmc   +1 more source

RECOVERY OF HEMOPOIETIC STROMAL PROGENITOR CELLS AFTER LETHAL TOTAL-BODY IRRADIATION AND BONE MARROW TRANSPLANTATION IN MICE

, 1985
Aldert H. Piersma, Kelvin G.M. Brockbank, Rob E. Ploemacher, Cecile P. E. Ottenheim   +3 more
openalex   +1 more source

Chimerism after whole organ transplantation: an explanation of renal and other organ acceptance [PDF]

, 1997
Demetris, AJ, Murase, N, Rao, AS, Starzl, TE, Thomson, AW, Trucco, M   +5 more
core  

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors. [PDF]

Bone Marrow Transplant
Galeano S, Bonfim C, Karduss A, Jaimovich G, Gómez-De León A, Bettarello G, Simione A, Correa C, Baldomero H, Neumann D, Basquiera AL, Berro M, Remaggi G, Amaru A, Barroso F, Seber A, Barriga F, Palma J, Puga B, Sánchez M, Herrera JM, Hernández C, Gómez-Almaguer D, Gaytán Morales F, Ruiz-Argüelles GJ, Mendoza N, Benítez ML, Wong A, Pagés C, Hernández M, Niederwieser D, Rondelli D, Frutos C.   +32 more
europepmc   +1 more source

SERUM 5ʼNUCLEOTIDASE AND ALKALINE PHOSPHATASE—HIGHLY PREDICTIVE LIVER FUNCTION TESTS FOR THE DIAGNOSIS OF GRAFT-VERSUS-HOST DISEASE IN BONE MARROW TRANSPLANT RECIPIENTS

, 1989
Walid G. Yasmineh, ALEXANDRA H. PILIPOVICH, Anthony A. Killeen   +2 more
openalex   +1 more source